Cargando…
Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus
HIV-infected people have started to live longer since the introduction of antiretroviral therapy, however various co-morbid illnesses have emerged. Three HIV-infected individuals, all at least 43 years old, reported with a new onset of type 2 diabetes after switching to dolutegravir-combined antiret...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874156/ https://www.ncbi.nlm.nih.gov/pubmed/35223037 http://dx.doi.org/10.1177/2050313X221079444 |